Crossmark

A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer

Crossref DOI link: https://doi.org/10.1007/s00262-024-03810-6

Published Online: 2024-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

von der Grün, Jens

Broglie, Martina

Guckenberger, Matthias

Balermpas, Panagiotis
Funding

Funding for this research was provided by:

University of Zurich
License Information

Text and Data Mining valid from 2024-09-05

Version of Record valid from 2024-09-05
More Information

Article History

Received: 23 April 2024

Accepted: 12 August 2024

First Online: 5 September 2024

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Hospital of Zurich, Switzerland (BASEC No. 2019-00993).

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below